Obalon Therapeutics, Inc.
OBLN · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,130 | -$12,334 | -$23,676 | -$37,380 |
| Dep. & Amort. | $22 | $843 | $894 | $581 |
| Deferred Tax | $6 | $0 | $0 | $0 |
| Stock-Based Comp. | $184 | $1,089 | $2,983 | $4,693 |
| Change in WC | $0 | -$11,469 | $2,842 | -$30,328 |
| Other Non-Cash | $2,491 | $11,462 | -$5,909 | $33,002 |
| Operating Cash Flow | -$4,427 | -$10,409 | -$22,866 | -$29,432 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$171 | -$194 | -$1,282 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$9,102 |
| Inv. Sales/Matur. | $0 | $0 | $2,550 | $29,901 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$171 | $2,356 | $19,517 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $23,377 | $9,823 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $677 | $430 | $13,378 | $9,994 |
| Financing Cash Flow | $677 | $430 | $13,378 | $9,994 |
| Forex Effect | -$16 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,766 | -$10,150 | -$7,132 | $79 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,559 | $14,055 | $21,187 | $21,108 |
| End Cash | $793 | $3,905 | $14,055 | $21,187 |
| Free Cash Flow | -$4,427 | -$10,580 | -$23,060 | -$30,714 |